Practical guide to exocrine pancreatic insufficiency – Breaking the myths

BackgroundExocrine pancreatic insufficiency (EPI) is characterized by a deficiency of exocrine pancreatic enzymes, resulting in malabsorption. Numerous conditions account for the etiology of EPI, with the most common being diseases of the pancreatic parenchyma including chronic pancreatitis, cystic fibrosis, and a history of extensive necrotizing acute pancreatitis. Treatment for EPI includes dietary management, lifestyle changes (i.e., decrease in alcohol consumption and smoking cessation), and pancreatic enzyme replacement therapy.DiscussionMany diagnostic tests are available to diagnose EPI, however, the criteria of choice remain unclear and the causes for a false-positive test are not yet understood. Despite multiple studies on the treatment of EPI using exogenous pancreatic enzymes, there remains confusion amongst medical practitioners with regard to the best approach to diagnose EPI, as well as dosing and administration of pancreatic enzymes.SummaryAppropriate use of diagnostics and treatment approaches using pancreatic enzymes in EPI is essential for patients. This opinion piece aims to address the existing myths, remove the current confusion, and function as a practical guide to the diagnosis and treatment of EPI.

[1]  J. Murray,et al.  Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. , 2003, Archives of internal medicine.

[2]  F. Guarner,et al.  Fate of oral enzymes in pancreatic insufficiency. , 1993, Gut.

[3]  A. Huebner,et al.  Pancreatic Elastase 1 in Feces of Preterm and Term Infants , 2001, Journal of pediatric gastroenterology and nutrition.

[4]  M. Wilschanski,et al.  Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[5]  U. Fölsch,et al.  Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. , 1996, Gut.

[6]  P. Lankisch [Chronic pancreatitis]. , 1991, Der Internist.

[7]  D. Meyerholz,et al.  Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology. , 2015, American journal of physiology. Gastrointestinal and liver physiology.

[8]  C. V. van Eijck,et al.  A Prospective Assessment of the Natural Course of the Exocrine Pancreatic Function in Patients With a Pancreatic Head Tumor , 2013, Journal of clinical gastroenterology.

[9]  D. Theriaque,et al.  Ranitidine and Omeprazole as Adjuvant Therapy to Pancrelipase to Improve Fat Absorption in Patients With Cystic Fibrosis , 2002, Journal of pediatric gastroenterology and nutrition.

[10]  E. Dimagno,et al.  The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. , 1994, Gastroenterology.

[11]  M. Corey,et al.  A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. , 1988, Journal of clinical epidemiology.

[12]  M. Corey,et al.  Combining unprotected pancreatic enzymes with pH-sensitive enteric-coated microspheres does not improve nutrient digestion in patients with cystic fibrosis. , 2005, The Journal of pediatrics.

[13]  Dhiraj Yadav,et al.  The epidemiology of pancreatitis and pancreatic cancer. , 2013, Gastroenterology.

[14]  R. Hubbard,et al.  Seroprevalence, correlates, and characteristics of undetected coeliac disease in England , 2003, Gut.

[15]  J. Iglesias-Garcia,et al.  The Spanish Pancreatic Club's recommendations for the diagnosis and treatment of chronic pancreatitis: part 2 (treatment). , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[16]  S. Caras,et al.  Pancrelipase Delayed-Release Capsules (CREON) for Exocrine Pancreatic Insufficiency due to Chronic Pancreatitis or Pancreatic Surgery: A Double-Blind Randomized Trial , 2010, The American Journal of Gastroenterology.

[17]  P. Durie,et al.  Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. , 1995, The Journal of pediatrics.

[18]  J. Lieb,et al.  Pancreatic function testing: here to stay for the 21st century. , 2008, World journal of gastroenterology.

[19]  L. Traverso,et al.  Exocrine function following the whipple operation as assessed by stool elastase , 2006, Journal of Gastrointestinal Surgery.

[20]  J. Dijkman,et al.  Improvement of fecal fat excretion after addition of omeprazole to pancrease in cystic fibrosis is related to residual exocrine function of the pancreas , 2005, Digestive Diseases and Sciences.

[21]  J. Semler,et al.  Intestinal pH and Gastrointestinal Transit Profiles in Cystic Fibrosis Patients Measured by Wireless Motility Capsule , 2013, Digestive Diseases and Sciences.

[22]  A. Andriulli,et al.  Italian consensus guidelines for chronic pancreatitis. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[23]  L. Gullo,et al.  Quality of life in patients with chronic pancreatitis. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[24]  E. Kuipers,et al.  Pancreatic enzyme replacement therapy in chronic pancreatitis. , 2010, Best practice & research. Clinical gastroenterology.

[25]  M. Bardella,et al.  Gallbladder emptying and somatostatin and cholecystokinin plasma levels in celiac disease , 1999, American Journal of Gastroenterology.

[26]  S. Barreto,et al.  The islet-acinar axis of the pancreas: more than just insulin. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[27]  D. Graham,et al.  Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century. , 2014, World journal of gastroenterology.

[28]  G. Cont,et al.  Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease , 2014, Journal of clinical gastroenterology.

[29]  P. Lewindon,et al.  Cystic fibrosis: An update for clinicians. Part 2: Hepatobiliary and pancreatic manifestations , 2014, Journal of gastroenterology and hepatology.

[30]  E. Kuipers,et al.  The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[31]  J. Domínguez-Muñoz,et al.  Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it? , 2011, Advances in medical sciences.

[32]  M. Falconi,et al.  Pancreatic insufficiency after different resections for benign tumours , 2007, The British journal of surgery.

[33]  D. Conwell,et al.  Pathogenesis of Chronic Pancreatitis: An Evidence-Based Review of Past Theories and Recent Developments , 2004, The American Journal of Gastroenterology.

[34]  J. Keller,et al.  Human pancreatic exocrine response to nutrients in health and disease , 2005, Gut.

[35]  G. Adler,et al.  Clinical evaluation of the faecal elastase test in the diagnosis and staging of chronic pancreatitis , 1996, European journal of gastroenterology & hepatology.

[36]  J. Meyer,et al.  Mismatch of Duodenal Deliveries of Dietary Fat and Pancreatin from Enterically Coated Microspheres , 1997, Pancreas.

[37]  C. Sempoux,et al.  Persistent decreased plasma cholecystokinin levels in celiac patients under gluten-free diet: respective roles of histological changes and nutrient hydrolysis , 2002, Regulatory Peptides.

[38]  A. Ruzzenente,et al.  Systematic review of central pancreatectomy and meta‐analysis of central versus distal pancreatectomy , 2013, The British journal of surgery.

[39]  Melissa R. Miller,et al.  Evidence for a Causal Relationship Between Early Exocrine Pancreatic Disease and Cystic Fibrosis–Related Diabetes: A Mendelian Randomization Study , 2014, Diabetes.

[40]  J. Neoptolemos,et al.  Exocrine Pancreatic Function following Pancreatectomy , 1999, Annals of the New York Academy of Sciences.

[41]  S. Ng,et al.  Drug therapies for reducing gastric acidity in people with cystic fibrosis. , 2016, The Cochrane database of systematic reviews.

[42]  S. Chari,et al.  International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas , 2006, Pancreatology.

[43]  L. Gullo,et al.  Fecal Elastase 1 Determination in Chronic Pancreatitis , 2004, Digestive Diseases and Sciences.

[44]  J. Neoptolemos,et al.  Partial Pancreatic Resection for Pancreatic Malignancy Is Associated with Sustained Pancreatic Exocrine Failure and Reduced Quality of Life: A Prospective Study , 2011, Pancreatology.

[45]  P. Hardt,et al.  Exocrine Pancreatic Insufficiency in Diabetes Mellitus: A Complication of Diabetic Neuropathy or a Different Type of Diabetes? , 2011, Experimental diabetes research.

[46]  D. Linder,et al.  Elastase 1 and chymotrypsin B in pancreatic juice and feces. , 1989, Clinical biochemistry.

[47]  W. Uhl,et al.  Early and late postoperative changes in the quality of life after pancreatic surgery , 2013, Langenbeck's Archives of Surgery.

[48]  E. Dimagno,et al.  Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. , 1977, The New England journal of medicine.

[49]  A. Bross,et al.  Duodenal Secretion and Fecal Excretion of Pancreatic Elastase‐1 in Healthy Humans and Patients with Chronic Pancreatitis , 1997, Pancreas.

[50]  E. Lebenthal,et al.  Development of functional responses in human exocrine pancreas. , 1980, Pediatrics.

[51]  R. Houwen,et al.  Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis , 2015, Journal of pediatric gastroenterology and nutrition.

[52]  J. Iglesias-Garcia,et al.  The Spanish Pancreatic Club recommendations for the diagnosis and treatment of chronic pancreatitis: part 1 (diagnosis). , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[53]  A. Berry Pancreatic enzyme replacement therapy during pancreatic insufficiency. , 2014, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[54]  M. McAlindon,et al.  Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms? , 2006, Alimentary pharmacology & therapeutics.

[55]  J. Barkin,et al.  Enzyme Content and Acid Stability of Enteric-Coated Pancreatic Enzyme Products In Vitro , 2005, Pancreas.

[56]  S. Freedman,et al.  Factors Determining Optimal Fatty Acid Absorption in Preterm Infants , 2016, Journal of pediatric gastroenterology and nutrition.

[57]  E. Kuipers,et al.  Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[58]  H. Witt,et al.  Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. , 2007, Gastroenterology.

[59]  B. Wilcken,et al.  Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. , 1990, The New England journal of medicine.

[60]  M. Armand,et al.  Enzyme replacement therapy for pancreatic insufficiency: present and future , 2011, Clinical and experimental gastroenterology.

[61]  L. Traverso,et al.  Pancreatic Exocrine Function Is Preserved After Distal Pancreatectomy , 2010, Journal of Gastrointestinal Surgery.

[62]  R. Laugier,et al.  In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability , 2007, Alimentary pharmacology & therapeutics.

[63]  M. Corey,et al.  How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? , 2002, The Journal of pediatrics.

[64]  J. Lloyd-Still,et al.  High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. , 1997, The New England journal of medicine.

[65]  M. Raimondo,et al.  Pancreatic Enzyme Pharmacotherapy , 2007, Pharmacotherapy.

[66]  M. Phillips Pancreatic exocrine insufficiency following pancreatic resection. , 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[67]  D. Adams,et al.  Operative management of chronic pancreatitis: longterm results in 372 patients. , 2007, Journal of the American College of Surgeons.

[68]  A. Stecenko,et al.  Clinical Pharmacology of Pancreatic Enzymes in Patients with Cystic Fibrosis and In Vitro Performance of Microencapsulated Formulations , 1994, Journal of clinical pharmacology.

[69]  A. Figueiras,et al.  Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three‐way crossover study , 2005, Alimentary pharmacology & therapeutics.

[70]  J. Singh,et al.  Mechanism of exocrine pancreatic insufficiency in streptozotocin-induced diabetes mellitus in rat: Effect of cholecystokinin-octapeptide , 2004, Molecular and Cellular Biochemistry.

[71]  M. Löhr,et al.  Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency , 1998, Gut.

[72]  E. Dimagno,et al.  Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. , 1973, The New England journal of medicine.

[73]  T. Stevens,et al.  Cigarette Smoking Is Independently Associated with Chronic Pancreatitis , 2010, Pancreatology.

[74]  R. Bretzel,et al.  Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c) , 2007, Diabetes/metabolism research and reviews.

[75]  J. Hendriks,et al.  Effects of a proton‐pump inhibitor in cystic fibrosis , 1998, Acta paediatrica.

[76]  M. Kakei,et al.  Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency , 2012, Core evidence.

[77]  B. Lindkvist Diagnosis and treatment of pancreatic exocrine insufficiency. , 2013, World journal of gastroenterology.

[78]  G. Capurso,et al.  Exocrine Pancreatic Insufficiency in Diabetic Patients: Prevalence, Mechanisms, and Treatment , 2015, International journal of endocrinology.

[79]  J. Windsor,et al.  Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[80]  J. Lloyd-Still Cystic fibrosis and colonic strictures. A new "iatrogenic" disease. , 1995, Journal of clinical gastroenterology.

[81]  M. Proesmans,et al.  Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes , 2003, European Journal of Pediatrics.